Back to Search
Start Over
S1605 HORIZON (OP-106): UPDATED EFFICACY AND SAFETY OF MELFLUFEN IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) REFRACTORY TO DARATUMUMAB (DARA) AND/OR POMALIDOMIDE (POM)
- Source :
- HemaSphere. 3:739
- Publication Year :
- 2019
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2019.
Details
- ISSN :
- 25729241
- Volume :
- 3
- Database :
- OpenAIRE
- Journal :
- HemaSphere
- Accession number :
- edsair.doi...........095eff044494d21f18b845c120d724ea